# A Study of YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia

> **NCT07287930** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Union Hospital, Tongji Medical College, Huazhong University of Science and Technology** · enrollment: 13 (estimated)

## Conditions studied

- Autoimmune Hemolytic Anemia

## Interventions

- **DRUG:** YTS109 cell

## Key facts

- **NCT ID:** NCT07287930
- **Lead sponsor:** Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-25
- **Primary completion:** 2026-12-25
- **Final completion:** 2027-12-26
- **Target enrollment:** 13 (ESTIMATED)
- **Last updated:** 2025-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07287930

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07287930, "A Study of YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07287930. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*